Who owns Enlivex Therapeutics Ltd?
- Ticker: ENLV
- CUSIP Number: m4130y106
Tip: Access positions for across all investors
Analyze quarterly positions in Enlivex Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enlivex Therapeutics stock
Who bought or sold Enlivex Therapeutics Ltd this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Diametric Capital | 1.5M | $1.4M | 100% | Mar 2026 |
|
| ARK Investment Management | 628k | $584k | 100% | Mar 2026 |
|
| Renaissance Technologies | 314k | $221k | 99% | Dec 2025 |
|
| Two Sigma Investments | 146k | $136k | -25% | Mar 2026 |
|
| UBS Group | 138k | $129k | 295% | Mar 2026 |
|
| Bank of America Corporation | 130k | $121k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 102k | $95k | 100% | Mar 2026 |
|
| Morgan Stanley | 98k | $92k | -51% | Mar 2026 |
|
| Geode Capital Management | 81k | $75k | 100% | Mar 2026 |
|
| XTX Topco | 62k | $44k | 45% | Dec 2025 |
|
| Invesco | 62k | $57k | 1% | Mar 2026 |
|
| Citadel Advisors | 52k | $48k | -14% | Mar 2026 |
|
| Virtu Financial | 47k | $33k | 100% | Dec 2025 |
|
| Two Sigma Securities | 20k | $19k | 100% | Mar 2026 |
|
| Prosperity Consulting Group | 18k | $16k | 0% | Mar 2026 |
|
| Harbour Investments | 16k | $15k | 100% | Mar 2026 |
|
| Millennium Management | 12k | $11k | 100% | Mar 2026 |
|
| Neuberger Berman Group | 11k | $7.7k | 0% | Dec 2025 |
|
| SkyView Investment Advisors | 10k | $7.0k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 9.4k | $8.7k | 2% | Mar 2026 |
|
| Simplex Trading | 8.9k | $6.2k | 100% | Dec 2025 |
|
| Mcguire Capital Advisors | 2.5k | $1.8k | 100% | Dec 2025 |
|
| Tower Research Capital | 2.2k | $1.6k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 2.1k | $1.5k | 0% | Dec 2025 |
|
| SRS Capital Advisors | 1.0k | $944.965000 | 0% | Mar 2026 |
|
| Activest Wealth Management | 1.0k | $930.000000 | 0% | Mar 2026 |
|
| Steward Partners Investment Advisory | 500.00 | $465.000000 | 0% | Mar 2026 |
|
| Group One Trading | 207.00 | $193.006800 | 100% | Mar 2026 |
|
| Red Tortoise | 150.00 | $139.995000 | 0% | Mar 2026 |
|
| TD Waterhouse Canada | 150.00 | $144.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Enlivex Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Dec 2025 | 154k | $108k |
| Jane Street | Dec 2025 | 74k | $52k |
| Susquehanna International | Sep 2025 | 55k | $57k |
| BFSG | Dec 2025 | 1.0k | $704.000000 |
| Jpmorgan Chase & Co | Sep 2025 | 100.00 | $104.000000 |
| Advisory Services Network | Sep 2025 | 43.00 | $44.999500 |